We are looking for young people 2–17 years old to join a Crohn’s disease clinical research to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe CD (including associated symptoms such as tiredness, loss of appetite, bloody stool, weight loss and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to take part.
